Playing both sides?: Branded sales, generic drugs, and antitrust policy

Journal article

Open access

Peer reviewed

Michael A Carrier, Mark A Lemley and Shawn Miller

The Hastings law journal, Vol.71(2), pp.307-358

02/14/2020

DOI:

https://doi.org/10.7282/00000047

Abstract

Generic drugs

Antitrust law

Research

Pharmaceutical industry

generics

antitrust

empirical studies

mergers

Intellectual Property

Pharmaceuticals

pdf

E-Carrier-et-al._12-TRANSMIT728.99 kBDownload View

Open Access

url

https://repository.uchastings.edu/hastings_law_journal/vol71/iss2/3/View

Version of Record (VoR) Hasting law journal

url

Report an accessibility issueView

Please complete a content remediation request to report an accessibility issue with a library electronic resource, website, or service.

200 File downloads

37 Record Views

Title: Subtitle: Playing both sides?: Branded sales, generic drugs, and antitrust policy
Creators: Michael A Carrier (Author)
Mark A Lemley (Author)
Shawn Miller (Author)
Publication Details: The Hastings law journal, Vol.71(2), pp.307-358
Date published: 02/14/2020
Publisher: Hastings College of the Law
Academic Unit: Rutgers Law School - Camden
Language: English
Resource Type: Journal article
Identifiers: 991031616949604646